Evaluation of the role of mast cells in the progression of acetic acid-induced colitis in mice

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 8, 1996, Pages 774-777

  Higa, A ^a   Ishikawa, N ^b   Eto, T ^b   Nawa, Y ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NONE

Author keywords

Acetic acid induced colitis; Inflammatory bowel disease; Ketotifen; Mast cell; Myeloperoxidase; Neutrophil

Indexed keywords

ACETIC ACID; KETOTIFEN; MYELOPEROXIDASE; STEM CELL FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; MALE; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; ONCOGENE C KIT; PRIORITY JOURNAL;

EID: 0030055795     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609010351     Document Type: Article

References (33)

1. Hall T. Allergy type. In: Roitt J, Brostoff J, Male D, editors. Essential immunology. London: Gower Medical Publishing, 1985:226-31.
2. Baum CA, Bhatia P, Miner PB. Increased colonic mucosal mast cells associated with severe watery diarrhea and microscopic colitis. Dig Dis Sci 1989;34:1462-5.
3. Stroble S, Busuttil A, Ferguson A. Human intestinal mucosal mast cells. Expanded population in untreated coeliac disease. Gut 1983;24:222-7.
4. Kosnai I, Kuitunen P, Savilahti, E, Sipponen P. Mast cells and eosinophils in the jejunal mucosa of patients with intestinal cow's milk allergy and celiac disease of childhood. J Pediatr Gastroenterol Nutr 1984;3:368-72.
5. Cherner JA, Jensen RT, Dubois A, O'Dorisio TM, Gardner JD, Metcalfe DD. Gastrointestinal function in systemic mastocytosis. Gastroenterology 1988;95:657-67.
6. Befus AD, Pearce FL, Gauldie J, Horsewood P, Bienenstock J. Mucosal mast cell. I. Isolation and functional characteristics of rat intestinal mast cells. J Immunol 1982; 128:2475-80.
7. 2 by immunologically activated rat intestinal mucosal mast cells. J Immunol 1988;140:1953-57.
8. Miller HRP, Woodbury J, Huntley JF, Newlands G. Systemic release of mucosal mast cell-protease in primed rats challenged with Nippostrogyus brasiliensis. Immunology 1983;49:471-9.
9. McQueen G, Marshall J, Perdeu MH, Siegel S, Bienenstock J. Pavlovian conditioning of rat mucosa mast cells to secrete rat mast cell protease II. Science 1989;243:83-5.
10. 4 in the pathogenesis of ethanol-induced gastric lesions in mice and their prevention by 5-lipoxigenase inhibitor AA-861, and leukotriene receptor antagonist FPL-55712. Gastroenterol Jap 1991;26:1-6.
11. Karmeli F, Eliakim R, Okon E, Rachmilewitz D. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer. Gastroenterology 1991;100:1206-16.
12. Beck PL, Morris GP, Wallace JL. Reduction of ethanol-induced gastric damage by sodium cromoglycate and FPL-52694. Role of leukotrienes, prostaglandins, and mast cells in the protective mechanism. Can J Physiol Pharmacol 1989;67:287-93.
13. Goosens J, Van Reempts J, Van Wauwe JP. Cytoprotective effects of disodium cromoglycate on rat stomach mucosa. Br J Pharmacol 1987;91:165-69.
14. Knutson L, Ahrenstedt O, Odlind B, Hallgren R. The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology 1990;98:849-54.
15. Blazs M, Illyes G, Vadasz G. Mast cells in ulcerative colitis: quantitative and ultrastructural studies. Virchows Arch [Cell Pathol] 1989;57:353-60.
16. Sarin SK, Malhotra V, Gupta SS, Karol A, Gaur SK, Anand BS. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 1987;32:363-7.
17. Lloyd G, Green HY, Fox H, Mani V, Turnberg LA. Mast cells and immunoglobulin E in inflammatory bowel disease. Gut 1975;16:861-6.
18. Chadwick VS. Etiology of chronic ulcerative colitis and Crohn's disease. In: Philips SF, Pemberton JH, Shoter RG, editors. The large intestine, Physiology, pathophysiology and disease. New York: Raven Press, 1991:445-63.
19. Eliakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and predonisolone. Gastroenterology 1988;95:1167-72.
20. 4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984;86:453-60.
21. Eliakim R, Karmeli F, Okon E, Rachmilewitz D. Ketotifen effectively prevents mucosal damage in experimental colitis. Gut 1992; 33:1498-503.
22. Willhelms OH. Inhibition profiles of picumast and ketotifen on the in vitro release of prostanoids, slow-reacting substance of anaphilaxis, histamine and enzyme from human leukocytes and rat alveolar macrophages. Int Arch Allergy Appl Immunol 1987;82:547-9.
23. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, et al. Stem cell factor is encoded at the S1 locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990;63:213-24.
24. d mice. Their value for the analysis of the role of mast cells in biologic responses in vivo. Am J Patholol 1987; 127:191-8.
25. v mice. Int Arch Allergy Appl Immunol 1986;80:85-94.
26. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
27. Abe T, Nawa Y. Worm expulsion and mucosal mast cell responses induce by IL-3 administration in strongyloides rattiinfected nude mice. Immunology 1988;63:181-5.
28. Wallace JL. Gulcocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but prostaglandin biosynthesis. Prostagladins 1987;34:311-23.
29. Bienenstock J, Befus AD, Pearce F. Mast cell heterogeneity: derivation and function, with emphasis on the intestine. J Allergy Clin Immunol 1982;70:407-12.
30. Boughton-Smith NK, Wallace JL, Whittle BJR. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in rat model of inflammatory bowel disease. Agents Actions 1988;25:115.
31. Noronha-Blob L, Lowe VC, Muhlhauser RO, Burch RM. NPC15669, an inhibitor of neutrophil recruitment, is efficacious in acetic acid-induced colitis in rats. Gastroenterology 1993;104: 1021-9.
32. Wallace JL, Higa A, McKnight GW, Maclntyre DU. Prevention and reversal pf experimental colitis by a monoclonal antibody which inhibits leukocyte adherence. Inflammation 1992;16:343-54.
33. Higa A, McKnight GW, Wallace JL. Attenuation of epithelial injury in acute experimental colitis by immunomodulators. Eur J Pharmacol 1993;239:171-6.